OLMA (STOCKS)
Olema Pharmaceuticals, Inc. Common Stock
$9.880000
+0.010000 (+0.10%)
Prev close: $9.870000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Sean P. Bohen
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $862.56M
- Employees
- 117
- P/E (TTM)
- -4.88
- P/B (TTM)
- 1.80
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $16.66M |
| Operating Expenses | $201.81M |
| Research and Development | $176.31M |
| Other Operating Expenses | $25.51M |
| Operating Income/Loss | -$201.81M |
| Income/Loss From Continuing Operations After Tax | -$185.15M |
| Income/Loss From Continuing Operations Before Tax | -$185.15M |
| Net Income/Loss | -$185.15M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$185.15M |
| Net Income/Loss Available To Common Stockholders, Basic | -$185.15M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.03 |
| Diluted Earnings Per Share | -$2.03 |
| Basic Average Shares | 275,482,694 |
| Diluted Average Shares | 275,482,694 |
| Assets | $530.65M |
| Current Assets | $513.23M |
| Cash | $505.30M |
| Other Current Assets | $7.93M |
| Noncurrent Assets | $17.42M |
| Fixed Assets | $356.00K |
| Other Non-current Assets | $17.06M |
| Liabilities | $50.17M |
| Current Liabilities | $47.17M |
| Accounts Payable | $3.72M |
| Wages | $2.78M |
| Other Current Liabilities | $40.67M |
| Noncurrent Liabilities | $3.00M |
| Equity | $480.48M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $480.48M |
| Liabilities And Equity | $530.65M |
| Net Cash Flow From Operating Activities | -$148.72M |
| Net Cash Flow From Operating Activities, Continuing | -$148.72M |
| Net Cash Flow From Investing Activities | -$106.15M |
| Net Cash Flow From Investing Activities, Continuing | -$106.15M |
| Net Cash Flow From Financing Activities | $256.78M |
| Net Cash Flow From Financing Activities, Continuing | $256.78M |
| Net Cash Flow | $1.91M |
| Net Cash Flow, Continuing | $1.91M |
| Comprehensive Income/Loss | -$186.03M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$186.03M |
| Other Comprehensive Income/Loss | -$86.88M |